Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders

International Journal of Antimicrobial Agents

Volumn 41, Issue 6, 2013, Pages 552-557

  Barnes, Kay B ^a   Steward, Jackie ^a   Thwaite, Joanne E ^a   Lever, M Stephen ^a   Davies, Carwyn H ^a   Armstrong, Stuart J ^a   Laws, Thomas R ^a   Roughley, Neil ^a   Harding, Sarah V ^a   Atkins, Timothy P ^a   Simpson, Andrew J H ^a   Atkins, Helen S ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Burkholderia; Co trimoxazole; Glanders; Melioidosis; Mouse models; Post exposure prophylaxis

Indexed keywords

COTRIMOXAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; GLANDERS; MAXIMUM PLASMA CONCENTRATION; MELIOIDOSIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; CHEMOPREVENTION; DISEASE MODELS, ANIMAL; FEMALE; GLANDERS; INHALATION EXPOSURE; MELIOIDOSIS; MICE; MICE, INBRED BALB C; POST-EXPOSURE PROPHYLAXIS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84877700385     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.02.007     Document Type: Article

References (27)

1. B.J. Currie, D.A. Fisher, N.M. Anstey, and S.P. Jacups Melioidosis: acute and chronic disease, relapse and re-activation Trans R Soc Trop Med Hyg 94 2000 301 304
2. B.J. Currie Advances and remaining uncertainties in the epidemiology of Burkholderia pseudomallei and melioidosis Trans R Soc Trop Med Hyg 102 2008 225 227
3. R.J. Hawley, and E.M. Eitzen Biological weapons-a primer for microbiologists Annu Rev Microbiol 55 2001 235 253
4. D.M. Wagg, and D. DeShazer Glanders, new insights into an old disease L.E. Lindler, F.J. Lebeda, G.W. Korch, Biological weapons defense: infectious diseases and counterterrorism 2004 Humana Press, Inc. Totowa, NJ 209 238
5. Health Protection Agency. Guidelines for action in the event of a deliberate release of glanders and melioidosis, V3.3. Updated 30 October 2008. http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/GlandersDR/ Guidance/ [accessed 15.02.13].
6. A.C. Cheng, and B.J. Currie Melioidosis: epidemiology, pathophysiology and management Clin Microbiol Rev 18 2005 383 416
7. F.M. Thibault, E. Hernandez, D.R. Vidal, M. Girardet, and J.D. Cavallo Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents J Antimicrob Chemother 54 2004 1134 1138
8. W. Chaowagul, W. Chierakul, A.J. Simpson, J.M. Short, K. Stepniewska, and B. Maharjan Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis Antimicrob Agents Chemother 49 2005 4020 4025
9. W. Chaowagul, A.J.H. Simpson, Y. Suputtamongkol, M.D. Smith, B.J. Angus, and N.J. White A comparison of chloramphenicol, trimethoprim-sulfamethoxazole and doxycycline with doxycycline alone as maintenance therapy for melioidosis Clin Infect Dis 29 1999 375 380
10. M.S. Lever, M. Nelson, A.J. Stagg, R.J. Beedham, and A.J.H. Simpson Experimental acute respiratory Burkholderia pseudomallei infection in BALB/c mice Int J Exp Pathol 90 2009 16 25
11. M.S. Lever, M. Nelson, P.I. Ireland, A.J. Stagg, R.J. Beedham, and G.A. Hall Experimental aerogenic Burkholderia mallei (glanders) infection in the BALB/c mouse J Med Microbiol 52 2003 1109 1115
12. J. Steward, T. Piercy, M.S. Lever, M. Nelson, A.J.H. Simpson, and T.J.G. Brooks Comparison of gatifloxacin, moxifloxacin and ciprofloxacin for treatment of experimental Burkholderia pseudomallei infection J Antimicrob Chemother 55 2005 523 527
13. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M7-A8. Wayne, PA: CLSI; 2009.
14. J. Steward, M.S. Lever, A.J.H. Simpson, A.M. Sefton, and T.J.G. Brooks Post-exposure prophylaxis and treatment of systemic anthrax in mice with fluoroquinolones J Antimicrob Chemother 54 2004 95 99
15. H.A. Druett A mobile form of the Henderson apparatus J Hyg (Lond) 67 1969 437 448
16. K.R. May, and G.J. Harper The efficiency of various liquid impinger samplers in bacterial aerosols Br J Ind Med 14 1957 287 297
17. A.C. Guyton Measurement of the respiratory volumes of laboratory animals Am J Physiol 150 1947 70 77
18. G.J. Harper, and Morton A method for measuring the retained dose in experiments on airborne infection J Hyg (Lond) 60 1962 249 257
19. D.J. Kenny, P. Russell, D. Rogers, S.M. Eley, and R.W. Titball In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp Antimicrob Agents Chemother 43 1999 2773 2775
20. S.P. Sivalingam, S.H. Sim, L.T. Aw, and E.E. Ooi Antibiotic susceptibility of 50 clinical isolates of Burkholderia pseudomallei from Singapore J Antimicrob Chemother 58 2006 1102 1103
21. D.A.B. Dance Melioidosis glanders 9th ed. L. Collier, A. Balows, M. Sussman, Topley and Wilson's microbiology and microbial infections Vol. 3 1998 Arnold London, UK 919 929
22. J.A. Piggott, and L. Hochholzer Human melioidosis: a histopathologic study of acute and chronic melioidosis Arch Pathol 90 1970 101 111
23. S.P. Sivalingam, S.H. Sim, L.C.W. Jasper, D. Wang, Y. Liu, and E.E. Ooi Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole J Antimicrob Chemother 61 2008 674 678
24. M. Vorachit, K. Lam, P. Jayanetra, and J.W. Costerton Resistance of Pseudomonas pseudomallei growing as a biofilm on silastic discs to ceftazidime and co-trimoxazole Antimicrob Agents Chemother 37 1993 2000 2002
25. C.A. Rowland, G. Lertmemongkolchai, A. Bancroft, A. Haque, M.S. Lever, and K.F. Griffin Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei Infect Immun 74 2006 5333 5340
26. A.C. Craig, and D. Andes Pharmacokinetics and pharmacodynamics of antibiotics in otitis media Pediatr Infect Dis J 15 1996 255 259
27. A.C. Cheng, E.S. McBryde, V. Wuthiekanun, W. Chierakul, P. Amornchai, and P.J. Day Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis Antimicrob Agents Chemother 53 2009 4193 4199